Find the latest funding information here.
For media enquiries please contact email@example.com or call +41 79 592 2005
Allecra Therapeutics is a clinical stage biopharmaceutical company dedicated to the development of novel treatments to combat multi drug-resistant bacterial infections. Its lead product candidate is in Phase 2 clinical trials for the treatment of multi-drug-resistant Gram-negative bacterial infections in the hospital
04/05/2017 Allecra Therapeutics Strengthens Leadership Team with Appointment of New Chairman and Chief Medical Officer
06/14/2016 Allecra Therapeutics Announces €22 Million Series B Financing
04/18/2013 New Anti-infectives Company, Allecra Therapeutics, created with €15 Million Series A Financing